只有看清资本背后的人长什么样子，才能理解他们手中的钱之于创新的作用。
Time：
2023-08-10 09:19
Author：
xieyijun
对话田文志：被“误读”的吉利德临床失利，与CD47靶点的应许之地
吉利德“翻车”，不仅引发业界对吉利德药物开发方案的质疑，各类解读更多指向了CD47靶点的成药性问题。
Time：
2023-08-09 09:16
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务